June 2023

​

We are thrilled to announce the Borchers' lab lineup for American Society for Mass Spectrometry (ASMS) 2023 in Houston, TX. We are presenting cutting-edge translational clinical research using quantitative proteomics.

​

Visit MRM Proteomics Inc. at Booth 914 to learn more about our collaboration in Protein Therapeutics and Quantitative Analysis of Disease Biomarkers. 

​

Join Christoph Borchers at the Agilent Technologies Breakfast meeting for the latest advancements in mass spectrometry.

​

May 2023 

We are pleased to announce the newly funded GAPP projects from Genome Canada, including the MutaQuant project.

​

Genome Canada: Genome Canada investments drive cutting edge R&D in health environmental sustainability and agricultural resilience.

Genome Quebec: An investment of nearly $16.5 million for health and environmental solutions

​

January 2023

We are very proud to announce that our scientist, Deema Qasrawi will be giving a podium presentation at the upcoming MSACL 2023 13th Annual Conference & Exhibits in Monterey, CA. Her presentation is entitled “A simplified proteomics LC-MRM-MS assay for determination of ApoE genotypes in plasma samples”. Make sure to attend her oral presentation in April.

 

We are thrilled to reveal that our lab technician, Dennis Lee has been accepted for a poster presentation at this year’s upcoming MSACL 2023 13th Annual Conference & Exhibits in Monterey, CA.  His presentation is entitled “LC-MS assay for antibiotics in intensive care unit clinical setting”. Be sure to stop by his poster presentation in April.

 

Read here to see the full program of the conference

 

December 2022

Dr. Christoph Borchers presented at the Agilent Technologies Breakfast Session at HUPO in Cancun. He spoke of new MRM approaches for faster, higher multiplex and sensitive protein quantitation from biological matrixes including blood and tissues.

 

Read more for full article: https://www.linkedin.com/posts/mrm-proteomics-inc-_dr-christoph-borchers-presented-this-morning-activity-7005965891964125184-tyGq/?utm_source=share&utm_medium=member_desktop

 

Two of our graduate students, Connie Sobsey and Georgia Mitsa presented at HUPO in Cancun during the Clinical Proteomics/Precision Medicine session. Georgia’s presentation is entitled “Clinical cancer research on metastases from refractory colorectal cancer using a multi-omics approach to improve current precision oncology treatment”. They identified several new therapeutic vulnerabilities and putative biomarkers to better inform clinical decision making. Connie’s presentation is entitled “Targeted proteomics to verify the association between translational control pathways and capivasertib response in cancer cell lines and patient tumours”.

​

November 2022

We welcome a new colleague, Yassene Mohammed to the Segal Cancer Proteomics Center.

 

October 2022

New funding announcement!

11 research teams from Québec's four institutions who received more than $4 million in major genomics funding were announced by Genome Québec in October.

One of the selected teams is led by Dr. Christoph Borchers.

 

Read more of the other 11 research teams: https://www.genomequebec.com/DATA/COMMUNIQUE/1377_fr~v~Plus_de_4_M_pour_des_solutions_genomiques_en_sante.pdf

 

September 2022

We are very happy to announce that our scientist, Deema Qasrawi will be giving an oral presentation at the upcoming MANA conference in Edmonton, AB. Her presentation is entitled “Multiplexed dilute-and-shoot LC-MRM-MS clinical assay for determination of the metanephrines and catecholamines in human urine”. Make sure to attend her oral presentation in September.

 

August 2022

Congratulations to the Segal Cancer Proteomics Centre for the renewal of the CFI-MSI funding for The Metabolomics Innovation Centre! See the complete story here to learn how Canada’s leading national research facilities received significant investments to drive research and innovation.

 

June 2022

We are very excited to announce that our scientist, Deema Qasrawi will be giving an oral presentation at the upcoming 70th ASMS Conference on Mass Spectrometry and Allied Topics in Minneapolis, MN. Her presentation is entitled “Multiplexed dilute-and-shoot LC-MRM-MS clinical assay for determination of the metanephrines and catecholamines in human urine”. Make sure to attend her presentation during the conference in June.

 

Congratulations Vincent Lacasse! Our PhD student of Dr. Borchers’ Lab took home the Gairdner poster award at the CSHRF+Gairdner symposium!

 

November 2021

We have exciting news to share! Dr. René Zahedi and Dr. Christoph Borchers have both been recently announced as the new co-editors for Expert Review of Proteomics. Click on the link for access to the full editorial board.

Click on the link for full access to the editorial board

​

February 2021

Molecular and Cellular Proteomics recently highlighted our paper "Proteomic Portraits Reveal Evolutionarily Conserved and Divergent Responses to Spinal Cord Injury" on their webpage!

 

Click on the link for full access to this article.

 

January 2020
The last decade was an eventful one for proteomics as the field saw a number of advances ranging from new workflows and applications to improvements in instrumentation and bioinformatic innovations. To get a sense of the key developments, we asked leading researchers in the field for their picks of the most notable achievements in proteomics throughout the 2010s. See the complete GenomeWeb story here. 

 

November 2019

Megagrant project from Center for Computational and Data-Intensive Science and Engineering have received funding from Russian Ministry of Science and High Education: Dr. Christoph Hermann Borchers and his new laboratory project “Next-Generation Proteomics to Improve Personalized Medicine and Health Care”. (Laboratory for Mass-spectroscopy), (duration 2 years, 33 mln RUB/yr).

 

August 2019

The UVic group has contributed 954 of the over 2350 targeted human and mouse MRM-based assays to the Assay Portal of the National Cancer Institute

 

April 2019

Doctoral candidate Georgia Mitsa of Dr. Christoph Borchers’ proteomics lab received two awards from McGill University:
• the Dr. Gerald B. Price Memorial Travel Award from the Department of Experimental Medicine; and the
• Grad Excellence Award in Experimental Medicine.  

 

September 2018
We welcome two new colleagues, Vanessa Gaspar working on an FRQS-funded project and Evgeniy Petrotchenko who is an expert in Structural Proteomics. Make sure to check out Part 1 of Agilent’s omics Webinar series on Jan 25th.

 

June 2018
We are proud to be part of the Montreal Cancer Consortium (MCC) that has been recently funded by the Terry Fox Foundation and other co-funders. “Working together, the MCC researchers will also aim to better understand how various aspects of the immune system relate to acute leukemia and why therapy works for some patients but not others. They hope to identify new biomarkers and novel targets that will respond to immunotherapy treatments.” See press release